Table 4 Univariate analysis of parameters influencing OS
From: Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma
HR (95% CI) | P-value | |
|---|---|---|
Gender (Male vs. Female) | 1.147(0.306–4.316) | 0.835 |
Age (>60 vs. ≦ 60) | 0.467 (0.085–1.681) | 0.2018 |
Histology (TNET vs. TC) | 2.424 (0.575–8.4415) | 0.2488 |
Tumor size (≧50mm vs<50) | 1.285(0.328–5.268) | 0.6982 |
Masaoka-Koga stage (I, II vs. III, IV) | 0 (0.047–1.206) | 0.083 |
Preoperative therapy (yes vs. no) | 1.108(0.237–5.151) | 0.897 |
Combined resection (yes vs. no) | 0.372(0.103–2.142) | 0.330 |
Lymph node meta (N0 vs. N1, 2) | 1.069 (0.2258–5.0589) | 0.9330 |
Resection status (R0 vs. R1, 2) | 0.193(0.001–0.515) | 0.017 |
Postoperative therapy (yes vs. no) | 1.545(0.398–6.354) | 0.510 |